M&A
SEER
May 22
▼ -0.25
Seer's Board of Directors unanimously rejected a revised unsolicited acquisition proposal from the Radoff-JEC Group valuing the company at $2.40 per share plus a contingent value r…
Dividend
BG
May 22
▲ +0.75
Bunge Global SA shareholders approved increased quarterly dividends of $0.72 per share at the 2026 AGM, representing a $0.02 increase from the prior year. The dividend increase sig…
Leadership
HSIC
May 22
▲ +0.70
Henry Schein's Board elected William K. Daniel as Independent Chairman effective May 21, 2026, succeeding Stanley M. Bergman who retired after 44 years. Daniel brings decades of he…
Offering
ENRT
May 22
▲ +0.50
Enertopia Corporation plans to raise up to CAD $800,000 through a private placement of 4 million units at CAD $0.20 per unit, each including a common share and warrant. Proceeds wi…
Other
NRON
May 22
— 0.00
Neuronetics amended and restated its consulting agreement with a consultant who previously served as interim principal accounting officer through May 2026. The agreement replaces p…
Earnings
BJ
May 22
▲ +0.70
BJ's Wholesale Club delivered strong first quarter results with comparable club sales up 6.3% year-over-year, driven by membership gains and digital growth of 28%. The company repo…
Regulatory
ASMB
May 22
▲ +0.75
Assembly Biosciences announced expansion of its oral NTCP inhibitor ABI-6250 into primary biliary cholangitis and primary sclerosing cholangitis, with a Phase 2 study anticipated t…
Earnings
BAH
May 22
▲ +0.55
Booz Allen Hamilton reported Q4 FY26 revenue of $2.8 billion, down 6.4% YoY, but net income increased 6.2% to $205 million as the company improved profitability margins. The compan…
Other
W
May 22
— 0.00
Wayfair Inc. filed an amendment to its 2023 Incentive Award Plan increasing the aggregate share reserve available for issuance under the plan. The modification expands the pool of …
Offering
SFSP
May 22
— 0.00
Starfighters Space, Inc. entered into a Securities Purchase Agreement dated May 22, 2026 with multiple investors to issue and sell company securities pursuant to Section 4(a)(2) of…
Regulatory
MNTS
May 22
— 0.00
Momentus amended its 2021 Equity Incentive Plan to increase Class A common stock reserves by 500,000 shares and raise the annual evergreen provision from 3.0% to 5.0%, pending stoc…
Regulatory
XOMA
May 22
— -0.10
XOMA Royalty Corporation amended its bylaws to opt out of Nevada acquiring company statutes and designate Nevada courts as the exclusive forum for internal disputes, while federal …
Regulatory
AGAE
May 22
▼ -0.30
All In FutureTech Alliance received a Nasdaq delisting notice on May 19, 2026 for non-compliance with timely filing requirements, but completed and filed its 2025 Annual Report on …
Buyback
NWS
May 21
▲ +0.50
News Corporation filed notice of an "other buy-back" type repurchase program authorizing up to $1 billion in aggregate purchases of its Class A Common Stock. The buyback program de…
Other
FNWB
May 21
— 0.00
First Northwest Bancorp filed an amended and restated 2020 Equity Incentive Plan governing stock options, restricted awards, and performance shares for employees and directors. The…
Regulatory
BIIB · DNLI
May 21
▼ -0.85
The Phase 2b LUMA study of BIIB122 failed to meet primary and secondary endpoints in early-stage Parkinson's disease, prompting discontinuation in idiopathic PD while continuing a …
Other
CATX
May 21
▲ +0.75
Perspective Therapeutics announced it will present updates on three radiopharmaceutical programs at the 2026 ASCO Annual Meeting, including positive interim data from its [212Pb]VM…
Other
EQS
May 21
— 0.00
Equus Total Return, Inc. issued a press release on May 21, 2026 announcing its net asset value for the quarter ended March 31, 2026. This quarterly NAV disclosure is standard repor…
Leadership
KSS
May 21
— 0.00
Kohl's Corporation amended and restated its Long-Term Compensation Plan to attract and retain key employees through equity and cash-based awards tied to company performance. The pl…
Regulatory
ZNTL
May 21
▲ +0.75
Zentalis Pharmaceuticals presented Phase 1b MUIR trial results showing 39% overall response rate and 7.3-month median PFS for azenosertib combined with paclitaxel in platinum-resis…